Daisuke Arai

3.0k total citations
48 papers, 876 citations indexed

About

Daisuke Arai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Daisuke Arai has authored 48 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Daisuke Arai's work include Lung Cancer Treatments and Mutations (16 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Epigenetics and DNA Methylation (5 papers). Daisuke Arai is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Epigenetics and DNA Methylation (5 papers). Daisuke Arai collaborates with scholars based in Japan, United States and France. Daisuke Arai's co-authors include Kenzo Soejima, Tomoko Betsuyaku, Katsuhiko Naoki, Kota Ishioka, Hiroyuki Yasuda, Keiko Ohgino, Junko Hamamoto, Tetsuo Tani, Takashi Sato and Ichiro Kawada and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Daisuke Arai

46 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Arai Japan 14 505 428 417 165 57 48 876
Pengfei Ren China 6 348 0.7× 422 1.0× 249 0.6× 225 1.4× 32 0.6× 16 756
Huikai Li China 16 152 0.3× 275 0.6× 218 0.5× 182 1.1× 179 3.1× 47 753
Lei Luo China 16 216 0.4× 216 0.5× 240 0.6× 251 1.5× 182 3.2× 46 819
Benny Johnson United States 16 198 0.4× 182 0.4× 501 1.2× 146 0.9× 131 2.3× 79 888
Steven Kregel United States 14 507 1.0× 616 1.4× 254 0.6× 256 1.6× 38 0.7× 23 1.1k
M Mousseau France 16 247 0.5× 170 0.4× 454 1.1× 87 0.5× 183 3.2× 55 823
Guanghui Gong China 20 309 0.6× 619 1.4× 265 0.6× 439 2.7× 171 3.0× 43 1.2k
Qian Pei China 19 113 0.2× 261 0.6× 306 0.7× 205 1.2× 99 1.7× 46 753
Yanjiang Han China 16 115 0.2× 183 0.4× 360 0.9× 188 1.1× 195 3.4× 57 911
Sudhakar Sahoo United Kingdom 11 100 0.2× 395 0.9× 228 0.5× 245 1.5× 32 0.6× 36 698

Countries citing papers authored by Daisuke Arai

Since Specialization
Citations

This map shows the geographic impact of Daisuke Arai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Arai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Arai more than expected).

Fields of papers citing papers by Daisuke Arai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Arai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Arai. The network helps show where Daisuke Arai may publish in the future.

Co-authorship network of co-authors of Daisuke Arai

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Arai. A scholar is included among the top collaborators of Daisuke Arai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Arai. Daisuke Arai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arai, Daisuke, Harumi Tsutsumi, Ryoya Nakagawa, et al.. (2025). AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model. JCI Insight. 10(5). 2 indexed citations
2.
Okada, Masahiko, Kohei Horiuchi, Koichi Sayama, et al.. (2024). Real-World Efficacy and Safety of Atezolizumab for Advanced Non-Small Cell Lung Cancer in Japan: A Retrospective Multicenter Analysis. Journal of Clinical Medicine. 13(24). 7815–7815. 1 indexed citations
3.
4.
Arai, Daisuke, Harumi Tsutsumi, Wado Akamatsu, et al.. (2023). Generation and characterization of a human iPSC line (JUFMDOi007-A) from a patient with Usher syndrome due to mutation in USH2A. Stem Cell Research. 69. 103100–103100. 3 indexed citations
5.
Kawachi, Hayato, Motohiro Tamiya, Yoshihiko Taniguchi, et al.. (2022). Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study. JTO Clinical and Research Reports. 3(7). 100355–100355. 10 indexed citations
6.
Kobayashi, Keigo, Ichiro Nakachi, Daisuke Arai, et al.. (2019). Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report. Clinical Lung Cancer. 21(1). e30–e32. 5 indexed citations
7.
Kobayashi, Keigo, Ichiro Nakachi, Katsuhiko Naoki, et al.. (2018). Real-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter Analysis. Clinical Lung Cancer. 19(3). e349–e358. 45 indexed citations
8.
Naoki, Katsuhiko, Yuichiro Takeda, Kenzo Soejima, et al.. (2017). A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab. Oncology Letters. 13(5). 3285–3290. 2 indexed citations
9.
Nishino, Makoto, Mari Ozaki, Ahmed E. Hegab, et al.. (2017). Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma. Journal of Cancer. 8(10). 1774–1785. 30 indexed citations
10.
Miyawaki, Masayoshi, Hiroyuki Yasuda, Tetsuo Tani, et al.. (2016). Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer. Molecular Cancer Research. 15(1). 106–114. 58 indexed citations
11.
Tani, Tetsuo, Hiroyuki Yasuda, Junko Hamamoto, et al.. (2015). Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK -Translocated Lung Cancer Cells. Molecular Cancer Therapeutics. 15(1). 162–171. 54 indexed citations
12.
Ikemura, Shinnosuke, Katsuhiko Naoki, Hiroyuki Yasuda, et al.. (2015). A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer. Japanese Journal of Clinical Oncology. 45(4). 356–361. 6 indexed citations
13.
Sato, Takashi, Kenzo Soejima, Eri Arai, et al.. (2015). Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer. Oncology Reports. 34(3). 1137–1145. 21 indexed citations
14.
Ohgino, Keiko, Hiroyuki Yasuda, Junko Hamamoto, et al.. (2015). Abstract 4: ABT-263 is effective in a subset of non-small cell lung cancer cell lines. Cancer Research. 75(15_Supplement). 4–4. 4 indexed citations
15.
Arai, Daisuke, et al.. (2014). Proposal and Simulation of UE-based Network Control Scheme for Avoiding LTE Signaling Spike. IEICE Technical Report; IEICE Tech. Rep.. 114(29). 25–30. 2 indexed citations
16.
Terai, Hideki, Kenzo Soejima, Hiroyuki Yasuda, et al.. (2014). Long-term exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFR-mutant PC9 lung cancer cell line. International Journal of Oncology. 46(1). 430–436. 12 indexed citations
17.
Suzuki, Takahiro, Hiroyuki Yasuda, Daisuke Arai, et al.. (2014). Multiple roles of extracellular fibroblast growth factors in lung cancer cells. International Journal of Oncology. 46(1). 423–429. 16 indexed citations
18.
Terai, Hideki, Kenzo Soejima, Hiroyuki Yasuda, et al.. (2013). Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC. Molecular Cancer Research. 11(7). 759–767. 174 indexed citations
19.
Ishii, Makoto, Koichiro Asano, Yuichiro Hayashi, et al.. (2012). Tuberous sclerosis diagnosed by incidental computed tomography findings of multifocal micronodular pneumocyte hyperplasia: a case report. Journal of Medical Case Reports. 6(1). 352–352. 1 indexed citations
20.
Arai, Daisuke, et al.. (2009). Proposal on ECO-friendly Data Center Operation Scheme. IEICE Technical Report; IEICE Tech. Rep.. 108(458). 469–474. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pengfei Ren Breakdown of academic impact, for papers by Huikai Li Breakdown of academic impact, for papers by Lei Luo Breakdown of academic impact, for papers by Benny Johnson Breakdown of academic impact, for papers by Steven Kregel Breakdown of academic impact, for papers by M Mousseau Breakdown of academic impact, for papers by Guanghui Gong Breakdown of academic impact, for papers by Qian Pei Breakdown of academic impact, for papers by Yanjiang Han Breakdown of academic impact, for papers by Sudhakar Sahoo
Rankless by CCL
2026